CNBCのインスタグラム(cnbc) - 1月25日 00時50分

Soon, growing a heart on demand may no longer be science fiction, but a reality. Around the world, start-ups — like Tokyo-based Cyfuse Biomedical — are emerging to develop such breakthroughs in the field of regenerative medicine. It is a market projected to reach $101.3 billion by 2022. This would be a huge scientific achievement, considering that in the United States, 118,950 people are registered in the Organ Procurement Transplantation Network.

[BIHAKUEN]UVシールド(UVShield) 更年期に悩んだら

>> 飲む日焼け止め！「UVシールド」を購入する